Logo image of BZAI

BLAIZE HOLDINGS INC (BZAI) Stock Fundamental Analysis

NASDAQ:BZAI - Nasdaq - US0929151076 - Common Stock - Currency: USD

2.58  +0.12 (+4.88%)

After market: 2.6 +0.02 (+0.78%)

Fundamental Rating

2

BZAI gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 110 industry peers in the Semiconductors & Semiconductor Equipment industry. BZAI may be in some trouble as it scores bad on both profitability and health. BZAI is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

BZAI had negative earnings in the past year.
In the past year BZAI has reported a negative cash flow from operations.
In the past 5 years BZAI reported 4 times negative net income.
BZAI had negative operating cash flow in 4 of the past 5 years.
BZAI Yearly Net Income VS EBIT VS OCF VS FCFBZAI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 -20M -40M -60M -80M

1.2 Ratios

The Return On Assets of BZAI (-212.02%) is worse than 98.18% of its industry peers.
Industry RankSector Rank
ROA -212.02%
ROE N/A
ROIC N/A
ROA(3y)-181.79%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BZAI Yearly ROA, ROE, ROICBZAI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 -200 -400

1.3 Margins

BZAI has a Gross Margin of 70.18%. This is amongst the best in the industry. BZAI outperforms 91.82% of its industry peers.
The Profit Margin and Operating Margin are not available for BZAI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 70.18%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
BZAI Yearly Profit, Operating, Gross MarginsBZAI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 -1K -2K -3K

More info and screens

2

2. Health

2.1 Basic Checks

BZAI does not have a ROIC to compare to the WACC, probably because it is not profitable.
BZAI has about the same amout of shares outstanding than it did 1 year ago.
Compared to 1 year ago, BZAI has an improved debt to assets ratio.
BZAI Yearly Shares OutstandingBZAI Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 20M 40M 60M 80M 100M
BZAI Yearly Total Debt VS Total AssetsBZAI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

BZAI has an Altman-Z score of -7.48. This is a bad value and indicates that BZAI is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -7.48, BZAI is doing worse than 80.91% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -7.48
ROIC/WACCN/A
WACC9.66%
BZAI Yearly LT Debt VS Equity VS FCFBZAI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 100M -100M 200M

2.3 Liquidity

A Current Ratio of 2.14 indicates that BZAI has no problem at all paying its short term obligations.
BZAI has a Current ratio of 2.14. This is in the lower half of the industry: BZAI underperforms 70.91% of its industry peers.
BZAI has a Quick Ratio of 1.93. This is a normal value and indicates that BZAI is financially healthy and should not expect problems in meeting its short term obligations.
BZAI has a Quick ratio (1.93) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 2.14
Quick Ratio 1.93
BZAI Yearly Current Assets VS Current LiabilitesBZAI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 50M 100M 150M

More info and screens

4

3. Growth

3.1 Past

BZAI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -1073.70%.
The Revenue has grown by 266.48% in the past year. This is a very strong growth!
EPS 1Y (TTM)-1073.7%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-877.25%
Revenue 1Y (TTM)266.48%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%83.42%

3.2 Future

The Earnings Per Share is expected to grow by 7.40% on average over the next years.
BZAI is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 784.26% yearly.
EPS Next Y-28.69%
EPS Next 2Y7.4%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year1679.6%
Revenue Next 2Y784.26%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

BZAI Yearly Revenue VS EstimatesBZAI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 2026 20M 40M 60M 80M 100M
BZAI Yearly EPS VS EstimatesBZAI Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 -0.2 -0.4 -0.6

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for BZAI. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for BZAI. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BZAI Price Earnings VS Forward Price EarningsBZAI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BZAI Per share dataBZAI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.5 -1 -1.5 -2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y7.4%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

BZAI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BLAIZE HOLDINGS INC

NASDAQ:BZAI (6/18/2025, 8:00:01 PM)

After market: 2.6 +0.02 (+0.78%)

2.58

+0.12 (+4.88%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)05-14 2025-05-14/amc
Earnings (Next)N/A N/A
Inst Owners40.98%
Inst Owner ChangeN/A
Ins Owners11.2%
Ins Owner Change16.88%
Market Cap262.33M
Analysts82.5
Price Target7.4 (186.82%)
Short Float %2.34%
Short Ratio4.06
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)-0.66%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-17.7%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 130.38
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-2.05
EYN/A
EPS(NY)-0.51
Fwd EYN/A
FCF(TTM)-0.62
FCFYN/A
OCF(TTM)-0.61
OCFYN/A
SpS0.02
BVpS-1.05
TBVpS-1.05
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -212.02%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 70.18%
FCFM N/A
ROA(3y)-181.79%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.02
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 168.2%
Cap/Sales 68.89%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.14
Quick Ratio 1.93
Altman-Z -7.48
F-Score3
WACC9.66%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1073.7%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-877.25%
EPS Next Y-28.69%
EPS Next 2Y7.4%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)266.48%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%83.42%
Revenue Next Year1679.6%
Revenue Next 2Y784.26%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-516.92%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-4340.49%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-4243.57%
OCF growth 3YN/A
OCF growth 5YN/A